Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current multicentre studies with the excimer laser: design and aims.

J E Tcheng1, A A Volkert-Noethen

  • 1Duke University Medical Center, Durham, NC 27710, USA.

Lasers in Medical Science
|August 4, 2001
PubMed
Summary

Excimer laser angioplasty is regaining traction for cardiovascular disease treatment. New clinical trials are investigating its effectiveness in complex cases like in-stent restenosis and peripheral artery disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GP IIb/IIIa blockade in elective percutaneous coronary intervention.

Current pharmaceutical design·2004
Same author

Impact of preprocedural white blood cell count on long term mortality after percutaneous coronary intervention: insights from the EPIC, EPILOG, and EPISTENT trials.

Heart (British Cardiac Society)·2003
Same author

Consequences of immunogenicity to the therapeutic monoclonal antibodies ReoPro and Remicade.

Developments in biologicals·2003
Same author

Eptifibatide in percutaneous coronary intervention. A review.

Minerva cardioangiologica·2002
Same author

Clinical pharmacology of higher dose eptifibatide in percutaneous coronary intervention (the PRIDE study).

The American journal of cardiology·2001
Same author

Effect of eptifibatide on angiographic complications during percutaneous coronary intervention in the IMPACT--(Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis) II Trial.

The American journal of cardiology·2001

Area of Science:

  • Cardiovascular Medicine
  • Medical Technology
  • Interventional Cardiology

Background:

  • Excimer laser ablation has a decade-long history in treating atherosclerotic plaque and cardiovascular disease.
  • Recent technological advancements and identified clinical needs are driving renewed interest in excimer laser angioplasty.

Purpose of the Study:

  • To describe the rationale and objectives of ongoing clinical trials evaluating excimer laser angioplasty.
  • To explore novel applications of excimer laser technology in challenging cardiovascular conditions.

Main Methods:

  • Overview of three key clinical trials: LARS (in-stent restenosis), PELA (occluded superficial femoral artery), and LACI (limb-threatening ischemia).
  • Focus on the comparative effectiveness and application of excimer laser angioplasty in specific patient populations.

Related Experiment Videos

Main Results:

  • The article focuses on the design and goals of the trials, not preliminary results.
  • The trials aim to establish the efficacy of excimer laser angioplasty in complex arterial blockages.

Conclusions:

  • Excimer laser angioplasty shows promise for treating difficult cardiovascular issues.
  • Ongoing trials are crucial for defining the expanded role of this technology in interventional cardiology.